Cue Biopharma (CUE) Cash & Current Investments (2017 - 2025)
Historic Cash & Current Investments for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $18.7 million.
- Cue Biopharma's Cash & Current Investments fell 4231.65% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 4231.65%. This contributed to the annual value of $23.4 million for FY2024, which is 5207.48% down from last year.
- Per Cue Biopharma's latest filing, its Cash & Current Investments stood at $18.7 million for Q3 2025, which was down 4231.65% from $28.0 million recorded in Q2 2025.
- In the past 5 years, Cue Biopharma's Cash & Current Investments ranged from a high of $76.3 million in Q4 2022 and a low of $14.0 million during Q1 2025
- Over the past 5 years, Cue Biopharma's median Cash & Current Investments value was $57.9 million (recorded in 2023), while the average stood at $50.7 million.
- Per our database at Business Quant, Cue Biopharma's Cash & Current Investments surged by 5033.24% in 2021 and then crashed by 6576.08% in 2025.
- Quarter analysis of 5 years shows Cue Biopharma's Cash & Current Investments stood at $64.4 million in 2021, then grew by 18.51% to $76.3 million in 2022, then crashed by 36.03% to $48.8 million in 2023, then tumbled by 52.07% to $23.4 million in 2024, then decreased by 20.04% to $18.7 million in 2025.
- Its Cash & Current Investments was $18.7 million in Q3 2025, compared to $28.0 million in Q2 2025 and $14.0 million in Q1 2025.